# ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

> **NCT01926054** · PHASE4 · WITHDRAWN · sponsor: **Ohio State University**

## Conditions studied

- SLE Glomerulonephritis Syndrome, WHO Class V

## Interventions

- **DRUG:** Acthar gel

## Key facts

- **NCT ID:** NCT01926054
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-07
- **Primary completion:** 2018-02
- **Final completion:** 2018-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2018-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926054, "ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01926054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*